PROF (Profound Medical) Change In Inventory: $-2.83 Mil (TTM As of Mar. 2026)

What is Profound Medical Change In Inventory?

Profound Medical PROF -1.77% 73 Change In Inventory is $-2.83 Mil as of Mar. 2026. GuruFocus rates PROF with a GF Score™ of 73/100 and a GF Value™ of $14.28 (Possible Value Trap). The stock has 1 warning sign investors should review.

Profound Medical's change in inventory for the quarter that ended in Mar. 2026 was $-1.00 Mil. It means Profound Medical's inventory increased by $1.00 Mil from Dec. 2025 to Mar. 2026 .

Profound Medical's change in inventory for the fiscal year that ended in Dec. 2025 was $-2.82 Mil. It means Profound Medical's inventory increased by $2.82 Mil from Dec. 2024 to Dec. 2025 .

Profound Medical's Total Inventories for the quarter that ended in Mar. 2026 was $9.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Profound Medical's Days Inventory for the quarter that ended in Mar. 2026 was 522.61.

Inventory Turnover measures how fast the company turns over its inventory within a year. Profound Medical's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.17.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Profound Medical's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 1.62.

Profound Medical (NAS:PROF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Profound Medical's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	8.6195	/	1.505	*	365 / 4
	=	522.61

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Profound Medical's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	1.505	/	8.6195
	=	0.17

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Profound Medical's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	8.6195	/	5.337
	=	1.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Profound Medical Change In Inventory Related Terms

Profound Medical Change In Inventory Historical Data

* Premium members only.

The historical data trend for Profound Medical's Change In Inventory can be seen below:

Profound Medical Change In Inventory Chart

Profound Medical Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Change In Inventory

Get a 7-Day Free Trial

-2.49

-1.86

0.35

0.66

-2.82

Profound Medical Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Change In Inventory	Get a 7-Day Free Trial															-0.98	-1.74	0.13	-0.23	-1.00

73GF Score

Profound Medical Corp PROF

Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Profound Medical Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.83 Mil.

Frequently Asked Questions Learn more about Change In Inventory →

What does a Change In Inventory of $-2.83 Mil mean?

Profound Medical (PROF) has a Change In Inventory of $-2.83 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Profound Medical and its competitors.

Is Profound Medical's Change In Inventory too high?

Profound Medical's current Change In Inventory is $-2.83 Mil. Overall, Profound Medical has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Profound Medical's Change In Inventory compare to ABT and SYK?

Profound Medical's Change In Inventory of $-2.83 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Change In Inventory for a Medical Devices & Instruments company?

A good Change In Inventory depends on the Medical Devices & Instruments industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Change In Inventory mean?

A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Profound Medical and its competitors. Profound Medical's current Change In Inventory is $-2.83 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Profound Medical stock overvalued right now?

Based on GuruFocus' analysis, Profound Medical (PROF) is currently considered Possible Value Trap. The stock's GF Value™ is $14.28, compared to a current price of $7.21 — trading 49.5% below its estimated fair value. The current Change In Inventory is $-2.83 Mil. Profound Medical's overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Change In Inventory calculated?

Change In Inventory is calculated from a company's financial statements. For Profound Medical (PROF), the current Change In Inventory is $-2.83 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Profound Medical (PROF) Overvalued in 2026?

Based on GuruFocus' analysis, Profound Medical stock appears to be undervalued. The current stock price of $7.21 is trading 49.5% below its estimated GF Value™ of $14.28. GuruFocus considers Profound Medical to be Possible Value Trap.

Key valuation signals for PROF:

Change In Inventory: $-2.83 Mil
GF Value™: $14.28 vs. price of $7.21 (49.5% below fair value)
GF Score™: 73/100 with 1 warning sign

No single metric tells the full story. See the PROF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Profound Medical Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies TSXV:TLT XCNQ:BLO XCNQ:VIVI TSXV:PINK TSXV:CHER TSXV:CNVI TSXV:VPT TSXV:ASG TSXV:MDX TSXV:VVTM ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Other Exchanges PRN:Canada

Address 2400 Skymark Avenue, Unit 6, Mississauga, ON, CAN, L4W 5K5

Website https://www.profoundmedical.com

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

73GF Score

Get the complete analysis for PROF

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.21

Price

$14.28

GF Value

View PROF Analysis

See Change In Inventory data for all stocks →